SCS-C007164

eupenicisirenin B

Pathway: Terpenoids Superclass: Sesquiterpenoids Class: Cyclobisabolane sesquiterpenoids

Chemical Structure

Structure of eupenicisirenin B
Loading 3D structure...
3D conformers are computationally generated from SMILES by RDKit for visualization and download; they are not experimental crystal or NMR structures.
Download: SDF SMILES

Source Information

Penicillium sp. SCSIO 41410 (soft coral-derived fungus)
Kingdom Fungi Phylum Ascomycota Class Eurotiomycetes Order Eurotiales Family Aspergillaceae Genus Penicillium Species NA
South China Sea
DOI: 10.1016/j.ejmech.2023.116068  · European Journal of Medicinal Chemistry

Drug-likeness (Lipinski Ro5)

Molecular Weight
196.2 Da
Threshold ≤ 500
ALogP
1.13
Threshold ≤ 5
H-Bond Donors
2
Threshold ≤ 5
H-Bond Acceptors
2
Threshold ≤ 10
Passes Lipinski Rule of Five — drug-like candidate

Chemical Properties

Molecular Formula:
C10H12O4
Molecular Weight:
196.2020 Da
SMILES:
CC1(C(=O)O)C2C=C(C(=O)O)CCC21
InChIKey:
KAEHGURFOWYTCN-UHFFFAOYSA-N
InChI:
InChI=1S/C10H12O4/c1-10(9(13)14)6-3-2-5(8(11)12)4-7(6)10/h4,6-7H,2-3H2,1H3,(H,11,12)(H,13,14)
Calculated Properties
ALogP:
1.128 lipophilicity
TPSA:
74.60 Ų polar surface area
H-Bond Donors:
2
H-Bond Acceptors:
2
Rotatable Bonds:
2
Ring Count:
2 (0 aromatic)
Chiral Centers:
3
Fsp³:
0.6000 fraction sp³ carbon

Database Information

Compound ID:
SCS-C007164
NPClassifier Pathway:
Terpenoids
NPClassifier Superclass:
Sesquiterpenoids
NPClassifier Class:
Cyclobisabolane sesquiterpenoids
Glycoside:
No
NPClassifier Status:
Classified
External Links:

Biological Activity Data

Activity values are displayed only when a quantitative or clearly reported result is available. Tested organisms, cell lines and molecular targets are shown under Target / model.
Activity Assay Target / model Result Reference
Anti-inflammatory — LPS-induced NF-κB activation Compounds 1, 6 and 14 were revealed with obvious NF-κB inhibitory activities at 20 μM. 10.1016/j.ejmech.2023.116068 European Journal of Medicinal Chemistry
Structure enlarged